PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,090,000 | -4.2% | 980,800 | -11.5% | 0.02% | -8.3% |
Q2 2020 | $3,224,000 | +15.0% | 1,107,900 | +11.4% | 0.02% | +4.3% |
Q1 2020 | $2,804,000 | -23.7% | 994,300 | -12.2% | 0.02% | -8.0% |
Q4 2019 | $3,673,000 | +27.9% | 1,132,000 | -14.9% | 0.02% | +25.0% |
Q3 2019 | $2,872,000 | -45.5% | 1,329,600 | -20.8% | 0.02% | -45.9% |
Q2 2019 | $5,272,000 | -15.8% | 1,678,900 | -0.3% | 0.04% | -17.8% |
Q1 2019 | $6,264,000 | +4220.0% | 1,683,800 | +2531.1% | 0.04% | +4400.0% |
Q1 2017 | $145,000 | -93.6% | 63,997 | -94.0% | 0.00% | -91.7% |
Q4 2016 | $2,269,000 | -70.5% | 1,070,509 | -53.4% | 0.01% | -66.7% |
Q3 2016 | $7,689,000 | -14.2% | 2,295,234 | -19.6% | 0.04% | -2.7% |
Q2 2016 | $8,959,000 | +9.5% | 2,853,102 | +16.1% | 0.04% | +19.4% |
Q1 2016 | $8,182,000 | +1075.6% | 2,457,115 | +1149.2% | 0.03% | +933.3% |
Q4 2015 | $696,000 | -30.5% | 196,700 | -1.2% | 0.00% | 0.0% |
Q3 2015 | $1,001,000 | +178.8% | 199,000 | +367.8% | 0.00% | +200.0% |
Q4 2013 | $359,000 | -5.3% | 42,543 | -10.6% | 0.00% | 0.0% |
Q3 2013 | $379,000 | -13.9% | 47,607 | -16.4% | 0.00% | 0.0% |
Q2 2013 | $440,000 | – | 56,933 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |